Keywords: لئومیوسارکوم رحم; Pericardial metastasis; Uterine leiomyosarcoma; Transesophageal echocardiography; Multidetector cardiac computed tomography; Cardiac magnetic resonance imaging;
مقالات ISI لئومیوسارکوم رحم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Clinical trials; Overall survival; Gynecologic oncology; Medical oncology; Sarcoma center;
Keywords: لئومیوسارکوم رحم; Laparoscopy; Morcellation; Myoma; Sarcoma; Uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine leiomyoma; Uterine leiomyosarcoma; Endometrial biopsy;
Keywords: لئومیوسارکوم رحم; morcellation; total laparoscopic hysterectomy; uterine leiomyosarcoma;
Keywords: لئومیوسارکوم رحم; Laparoscopic myomectomy; Laparoscopic supracervical hysterectomy; Leiomyosarcoma; Power morcellation; Uterine leiomyosarcoma; Uterine tissue extraction;
Keywords: لئومیوسارکوم رحم; morcellation; outcome; Stage 1; uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; FDR; false discovery rate; FFPE; formalin-fixed and paraffin-embedded; GSEA; gene set enrichment analysis; LMS; leiomyosarcoma; MSKCC; Memorial Sloan Kettering Cancer Center; NL; normal myometrium; OS; overall survival; PFS; progression-free survival; ULM
Keywords: لئومیوسارکوم رحم; Overall survival; systematic review; systemic chemotherapy; toxicity; uterine leiomyosarcoma;
Role of bevacizumab in uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Adjuvant; Bevacizumab; Chemotherapy; Survival; Uterine leiomyosarcoma;
Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations
Keywords: لئومیوسارکوم رحم; Uterine leiomyoma; Uterine leiomyosarcoma; Power morcellation; Preoperative assessment;
A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D
Keywords: لئومیوسارکوم رحم; Alisertib; Aurora kinase; Uterine leiomyosarcoma;
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Adjuvant chemotherapy; Gemcitabine; Docetaxel; Survival;
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Keywords: لئومیوسارکوم رحم; Trabectedin; Dacarbazine; Uterine leiomyosarcoma; Phase 3;
Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays
Keywords: لئومیوسارکوم رحم; Uterine leiomyoma; uterine leiomyosarcoma; MED12 mutation negative; whole exome sequencing; whole genome copy number analysis;
Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Chemotherapy; Radiotherapy; Adjuvant; Survival;
Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Brain metastasis; Pazopanib
Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review
Keywords: لئومیوسارکوم رحم; targeted therapy; uterine endometrial stromal sarcoma; uterine leiomyosarcoma; uterine sarcoma;
A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic Oncology Group Study
Keywords: لئومیوسارکوم رحم; Ixabepilone; Uterine leiomyosarcoma;
Adjuvant chemotherapy in stage I–II uterine leiomyosarcoma: A multicentric retrospective study of 140 patients
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Adjuvant therapy; Chemotherapy; Prognostic factors
Gene expression signatures of primary and metastatic uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Gene expression array; Uterine leiomyosarcoma; Metastasis
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Adjuvant therapy; Chemotherapy
Léiomyosarcomes utérins : épidémiologie, histologie, biologie, diagnostic, pronostic et traitement
Keywords: لئومیوسارکوم رحم; léiomyosarcome utérin; maladie rare; chimiothérapie; pluridisciplinarité; uterine leiomyosarcoma; rare disease; chemotherapy; multidisciplinarity;
Leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Leiomyosarcoma; Chemotherapy; Targeted therapy; Prognostic factors; Uterine leiomyosarcoma;
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Estrogen receptor; Progesterone receptor; Uterine leiomyosarcoma; Outcome
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia
Keywords: لئومیوسارکوم رحم; Carcinosarcoma; Uterine leiomyosarcoma; Phase II; Aflibercept (VEGF Trap)
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Surgery; Cytoreduction; Metastasis; Outcome
Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma
Keywords: لئومیوسارکوم رحم; Retinoblastoma; Uterine leiomyosarcoma; Secondary cancers;
Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: Morphological significance of calponin h1
Keywords: لئومیوسارکوم رحم; LMP2; Calponin h1; Uterine leiomyosarcoma; Cell morphology
Disseminated Peritoneal Leiomyosarcomas After Laparoscopic “Myomectomy” and Morcellation
Keywords: لئومیوسارکوم رحم; Laparoscopy; Morcellation; Myomectomy; Peritoneal leiomyosarcoma; Uterine leiomyosarcoma
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Uterine sarcoma; Tumor morcellation; Treatment outcomes
Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition
Keywords: لئومیوسارکوم رحم; Curcumin; Uterine leiomyosarcoma; mTOR; p70S6; S6; Apoptosis
Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas
Keywords: لئومیوسارکوم رحم; uterine leiomyosarcoma; carcinosarcoma; high undifferentiated sarcoma; chemotherapy
Uterine sarcomas—Recent progress and future challenges
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Endometrial stromal sarcoma; Undifferentiated endometrial sarcoma
Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential
Keywords: لئومیوسارکوم رحم; uterine leiomyosarcoma; epithelioid leiomyosarcoma; myxoid leiomyosarcoma; uterine smooth muscle tumour of uncertain malignant potential; STUMP; atypical leiomyoma
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Aromatase inhibitor
Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Gemcitabine; Docetaxel; Resected stage I-IV
Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Sunitinib
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine sarcoma; Leiomyosarcoma; AJCC; FIGO; Staging system; Uterine leiomyosarcoma; Predictive value
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
Keywords: لئومیوسارکوم رحم; Gemcitabine; Docetaxel; Uterine leiomyosarcoma
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Gemcitabine; Docetaxel
Bloodless Surgery in a Jehovah’s Witness Patient with a 12.7-kg Uterine Leiomyosarcoma
Keywords: لئومیوسارکوم رحم; uterine leiomyosarcoma; Jehovah’s Witness; anemia; bloodless surgeryPatient Care; Medical Knowledge; Systems Based Practice
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: A gynecologic oncology group study
Keywords: لئومیوسارکوم رحم; Thalidomide; Refractory leiomyosarcoma; Uterine leiomyosarcoma; Vascular endothelial growth factor
Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: An immunohistochemical study
Keywords: لئومیوسارکوم رحم; Thrombospondin 1 expression; Uterine leiomyosarcoma; Uterine smooth muscle tumor of uncertain malignant potential; Leiomyoma; Clinicopathologic parameters
Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Apoptosis; p53; p21; bcl-2; Bax; Tissue microarray
Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Adjuvant therapy; Chemotherapy; Prognostic factors
Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: A Gynecologic Oncology Group study
Keywords: لئومیوسارکوم رحم; Dacarbazine; Mitomycin; Doxorubicin; Cisplatin; Uterine leiomyosarcoma;
Subcutaneous Epithelioid Sarcoma Originating from Multiple Metastases of Uterine Leiomyosarcoma
Keywords: لئومیوسارکوم رحم; skin metastases; subcutaneous nodule; uterine leiomyosarcoma;
Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis
Keywords: لئومیوسارکوم رحم; p16 expression; Uterine leiomyosarcoma; Uterine smooth muscle tumor of uncertain malignant potential; Leiomyoma;
Array comparative genomic hybridization analysis of uterine leiomyosarcoma
Keywords: لئومیوسارکوم رحم; Uterine leiomyosarcoma; Array-based comparative genomic hybridization;